Citigroup Reiterates Buy Rating, $60 PT on CVS Caremark Corporation

In a report published Monday, Citigroup reiterated its Buy rating and $60.00 price target on CVS Caremark Corporation CVS. Citigroup noted, “We expect investors to focus on: 1) WAG/ESRX script retention; 2) the 2013 PBM selling season; 3) PBM streamlining initiatives; 4) opportunities to drive utilization, incl. Maintenance Choice (MC), generics, and healthcare reform; 5) specialty; 6) int'l expansion; and 7) capital allocation. CVS's unique business model continues to gain traction, and we anticipate optimistic 2013 guidance to be provided. CVS is Buy-rated and on Citi's Top Picks Live! list.” CVS Caremark Corporation closed on Friday at $47.23.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: Analyst ColorReiterationAnalyst RatingsCitigroup
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!